Evidence map›Paper›PMID 30709662›Full record

ArticleKidney international2019

Metabolomics assessment reveals oxidative stress and altered energy production in the heart after ischemic acute kidney injury in mice.

Benjamin M Fox, Hyo-Wook Gil, Lara Kirkbride-Romeo, Rushita A Bagchi, Sara A Wennersten, Korey R Haefner, Nataliya I Skrypnyk, Carolyn N Brown, Danielle E Soranno, Katja M Gist and 10 more

Abstract read
In one paragraph

Article in Kidney international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. A Stable Isotope Tracing Primer for the Mass Spectrometrist.Annual review of analytical chemistry (Palo Alto, Calif.) · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. High-Throughput Metabolomics in Transfusion Medicine.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Benjamin M FoxDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, Colorado, USA.
Hyo-Wook GilDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, Colorado, USA; Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Republic of Korea.
Lara Kirkbride-RomeoDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, Colorado, USA.
Rushita A BagchiDivision of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA; Consortium for Fibrosis Research and Translation, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Sara A WennerstenDivision of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA; Consortium for Fibrosis Research and Translation, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Korey R HaefnerDepartment of Pediatrics and Bioengineering, University of Colorado Denver, Aurora, Colorado, USA; Division of Pediatric Cardiology, Department of Pediatrics, University of Colorado Denver, Children's Hospital Colorado, Aurora, Colorado, USA.
Nataliya I SkrypnykDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, Colorado, USA.
Carolyn N BrownDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, Colorado, USA.
Danielle E SorannoDepartment of Pediatrics and Bioengineering, University of Colorado Denver, Aurora, Colorado, USA.
Katja M GistDivision of Pediatric Cardiology, Department of Pediatrics, University of Colorado Denver, Children's Hospital Colorado, Aurora, Colorado, USA.
Benjamin R GriffinDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, Colorado, USA.
Anna JovanovichDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, Colorado, USA.
Julie A ReiszDepartment of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, Aurora, Colorado, USA.
Matthew J WitherDepartment of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, Aurora, Colorado, USA.
Angelo D'AlessandroDepartment of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, Aurora, Colorado, USA.
Charles L EdelsteinDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, Colorado, USA; Denver VA Medical Center, Division of Nephrology, Department of Medicine, Denver, Colorado, USA.
Nathan ClendenenDepartment of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Timothy A McKinseyDivision of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA; Consortium for Fibrosis Research and Translation, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Christopher AltmannDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, Colorado, USA.
Sarah FaubelDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, Colorado, USA; Denver VA Medical Center, Division of Nephrology, Department of Medicine, Denver, Colorado, USA. Electronic address: Sarah.faubel@ucdenver.edu.

Funding

Regulation of Chromatin Signaling in Heart Failure by the BRD4 Bromodomain Protein.R01HL127240 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MCKINSEY, TIMOTHY, SRIVASTAVA, DEEPAK · 2015 to 2022
$6.4M
PREDOCTORAL TRAINING PROGRAM IN PHARMACOLOGYT32GM007635 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI DELL'ACQUA, MARK L · 1985 to 2023
$6.1M
Deacetylase-Dependent Control of Diastolic Dysfunction and HFpEFR01HL147558 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI HOUSER, STEVEN R, MCKINSEY, TIMOTHY · 2019 to 2022
$3.1M
Regulation of Cardiac Signaling by Class I Histone DeacetylasesR01HL116848 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MCKINSEY, TIMOTHY · 2013 to 2021
$3.1M
Acute Renal Failure Mediated Lung InjuryR01HL095363 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI FAUBEL, SARAH G · 2009 to 2013
$1.8M
The role of acute kidney in the pathogenesis of sepsis from pneumoniaR01HL130084 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI FAUBEL, SARAH G · 2016 to 2019
$1.5M
Local delivery of mesenchymal stem cells via injectable hyaluronic acid hydrogels to treat acute kidney injury and prevent progression of chronic kidney diseaseK08DK109226 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI SORANNO, DANIELLE ELISE · 2017 to 2021
$860k
Isoform-Selective HDAC Inhibitors for Age-Associated Diastolic DysfunctionR21AG043822 · NIA · UNIVERSITY OF COLORADO DENVER · PI MCKINSEY, TIMOTHY · 2012 to 2013
$414k
Mechanisms of susceptibility to sepsis after acute kidney injuryR56HL095363 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI FAUBEL, SARAH G · 2015 to 2015
$389k
The anti-inflammatory response after acute kidney injuryI01BX001498 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI FAUBEL, SARAH G · 2013 to 2016
–
BLRD VA I01 BX001498BLRD VA I01 BX003803NHLBI NIH HHS R01 HL095363NHLBI NIH HHS R01 HL116848NHLBI NIH HHS R01 HL127240NHLBI NIH HHS R01 HL130084NHLBI NIH HHS R01 HL147558NHLBI NIH HHS R56 HL095363NIA NIH HHS R21 AG043822NIDDK NIH HHS K08 DK109226NIGMS NIH HHS T32 GM007635
6 · The paper itself

Abstract

Acute kidney injury (AKI) is a systemic disease associated with widespread effects on distant organs, including the heart. Normal cardiac function is dependent on constant ATP generation, and the preferred method of energy production is via oxidative phosphorylation. Following direct ischemic cardiac injury, the cardiac metabolome is characterized by inadequate oxidative phosphorylation, increased oxidative stress, and increased alternate energy utilization. We assessed the impact of ischemic AKI on the metabolomics profile in the heart. Ischemic AKI was induced by 22 minutes of renal pedicle clamping, and 124 metabolites were measured in the heart at 4 hours, 24 hours, and 7 days post-procedure. Forty-one percent of measured metabolites were affected, with the most prominent changes observed 24 hours post-AKI. The post-AKI cardiac metabolome was characterized by amino acid depletion, increased oxidative stress, and evidence of alternative energy production, including a shift to anaerobic forms of energy production. These metabolomic effects were associated with significant cardiac ATP depletion and with echocardiographic evidence of diastolic dysfunction. In the kidney, metabolomics analysis revealed shifts suggestive of energy depletion and oxidative stress, which were reflected systemically in the plasma. This is the first study to examine the cardiac metabolome after AKI, and demonstrates that effects of ischemic AKI on the heart are akin to the effects of direct ischemic cardiac injury.

Indexed as

Oxidative StressAcute Kidney InjuryAnimalsCardio-Renal SyndromeDisease Models, AnimalEchocardiographyEnergy MetabolismHeartHeart Failure, DiastolicHumansIschemiaKidneyMaleMetabolomeMetabolomicsMiceacute kidney injurycardiorenal syndromemetabolomicsorgan crosstalk

Identifiers

PMID30709662
PMCPMC6564679

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.